180 results
Page 5 of 9
6-K
EX-1
l1v69
28 May 19
Current report (foreign)
7:04am
6-K
EX-99
pk0g a06v
14 May 19
BioLineRx Reports First Quarter 2019 Financial Results
7:00am
6-K
EX-99
2jgv08rszcxo y8m
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-99
dk768thf lag8pc6
7 Feb 19
As Representative of the several Underwriters
12:00pm
424B5
0caihtowed2s1f2
5 Feb 19
Prospectus supplement for primary offering
5:12pm
424B5
htpfajeq0ecj84qowh
4 Feb 19
Prospectus supplement for primary offering
5:52pm
6-K
EX-99
fl8pxa xvmbv
8 Nov 18
BioLineRx Reports Significant Progress Across Oncology
7:00am
6-K
EX-10.3
yuglfvhjshv8gt hbv0
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-99
3i00u890238fpqs5sz
13 Aug 18
BioLineRx Reports Second Quarter 2018 Financial Results
7:01am
6-K
EX-99
wdvkw0vpzy p91wy1ow
13 Aug 18
BioLineRx Reports Second Quarter 2018 Financial Results
7:01am
6-K
EX-99
l08l4 taocr
7 Aug 18
BioLineRx Announces Positive Results of Lead-in Period
7:00am
6-K
EX-99
04828h5xygwg5wb
22 May 18
BioLineRx Reports First Quarter 2018 Financial Results
7:00am
6-K
EX-99
9owo4j4 on3tekc2f
22 May 18
BioLineRx Reports First Quarter 2018 Financial Results
7:00am